Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?
about
Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.Combinatorial Therapies After Spinal Cord Injury: How Can Biomaterials Help?Cell transplantation therapy for spinal cord injury.Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases.Using Biomaterials to Promote Pro-Regenerative Glial Phenotypes After Nervous System Injuries.Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination
P2860
Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Does the preclinical evidence ...... rogression to clinical trials?
@en
type
label
Does the preclinical evidence ...... rogression to clinical trials?
@en
prefLabel
Does the preclinical evidence ...... rogression to clinical trials?
@en
P2093
P2860
P1476
Does the preclinical evidence ...... rogression to clinical trials?
@en
P2093
Andrew N Bankston
Darlene A Burke
Scott A Myers
Scott R Whittemore
Sujata Saraswat Ohri
P2860
P304
P356
10.1016/J.EXPNEUROL.2016.04.009
P407
P577
2016-04-13T00:00:00Z